NEW YORK (360Dx) – An integrated microfluidic prototype that uses a multistep process to capture and identify peptides could detect the risk of pregnant women having preterm births, according to its developers at Brigham Young University.

The research, funded by the National Institute of Biomedical Imaging Bioengineering, has yielded a microfluidic chip and nine biomarkers that the developers hope could one day can be incorporated into a single panel in a clinical test.  

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

A trial upgrade to 360Dx Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.